PAR 4.84% 29.5¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-82

  1. 827 Posts.
    lightbulb Created with Sketch. 207
    Having seen my wife riddled with pain and loss of mobility through Polymyalgia Rheumatica (chronic inflammation) a debilitating illness to say the least, drugs are all about delivering less pain and more function and the safer the drug the better, she has been offered some really nasty ones(Methotrexate) is one, fortunately we chose another avenue that has worked wonders for her, one that is plant based and much much safer, anecdotally we know this one works which after all this time holding is the reason i still do and i know we must cross the t's and dot the i's but at the end of the day when your in constant pain all you want is relief this drug will offer that i believe.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
-0.015(4.84%)
Mkt cap ! $103.1M
Open High Low Value Volume
30.5¢ 30.5¢ 29.5¢ $86.19K 286.7K

Buyers (Bids)

No. Vol. Price($)
4 70151 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 18600 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.